CClinicalTrials.gg
Status unknownNCT02718339Updated Mar 24, 2016

In-patient Asthma Counseling by Pulmonologist and Hospital Re-admission Rate

An interventional study of Intensive counseling in Asthma, sponsored by Soroka University Medical Center. Status unknown. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-03-24.

Sponsored by Soroka University Medical Center · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Mar 2016), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
164
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Prospective randomized clinical trial to assess the effect of in-hospital intensive counseling and follow-up vs. usual care, on re-admission rates of patients with Asthma.

The study population will include asthma patients admitted to internal Medicine departments and medical ICU at Soroka University Medical Center, due to asthma exacerbation.

02

Conditions studied

  • Asthma

Browse trials for

03

In context

Asthma

3,921 studies on the registry are indexed under Asthma; 507 are open to participants now.

This study's planned enrollment of 164 is above the median of 83 across 2,752 interventional studies indexed under Asthma.

Browse Asthma studies →

Lead sponsor

Soroka University Medical Center is the lead sponsor of 157 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Males and females ≥ 18 years old.
  2. Admitted to Internal Medicine at Soroka University Medical Center due to asthma exacerbation.

Exclusion criteria

Exclusion Criteria:

  1. Substance abuse (except for tobacco).
  2. Handicapped or bed ridden patients.
  3. Patients who don't speak Hebrew, English, Russian or Arabic.
  4. Other significant respiratory disease such as COPD, interstitial lung disease (as decided by the PI).
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
164 participants (estimated)

Study arms

  • Experimental
    Intensive counseling by a pulmonologist

    Counselor visit during hospitalization, telephone follow up for 4 weeks and a follow up visits.

    Behavioral: Intensive counseling

  • No intervention
    Usual care

Interventions

  • BehavioralIntensive counseling
06

What researchers measure

Primary outcomes

  1. Re-admission rate

    Time frame: Within 6 months after discharge

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 24, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02718339
Lead sponsor
Soroka University Medical Center
Responsible party
Sponsor
First posted
Mar 24, 2016
Start date
Apr 2016
Primary completion
Nov 2018 (estimated)
Completion
Nov 2019 (estimated)
Last update
Mar 24, 2016

Study contacts

Nimrod Maimon, MD
Contact
972-8-6403417

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion